The differences in Pax-2 expression between pRCC and ccRCC on one hand, and chrRCC and oncocytoma, on the other, may be related with the site of origin of each tumour type and may, thus, reflect distinct carcinogenic pathways. The gene discussed is PAX2; the disease is nonpapillary renal cell carcinoma.